The Committee of the 4th European NF-κB Subunit Workshop is now accepting applications for sponsorship from interested companies within the NF-κB and other affiliated sectors.
The workshop is held biennially and previous meetings have taken place in Germany, Scotland and Greece. We are excited to bring the 4th Subunit Workshop to the French Riviera in 2018. In 2016 we had 68 attendees from 11 countries around the world.
The workshop is organised by scientists working directly in this field. Funding relies solely on registration fees from participants and sponsorship from medical charities and companies. If you would like to help sponsor this meeting or just come along to learn more about this fascinating and important area of biology we would love to hear from you.
Please e-mail Fiona McGillivray, firstname.lastname@example.org, if you wish to discuss the opportunities available.
We are delighted to have the following sponsors of the 4th European NF-κB Subunit Workshop confirmed.
Biomedicines (ISSN 2227-9059) is an open access journal devoted to research of naturally driven biomedicines, pharmaceuticals, and biopharmaceutical products. The aim of Biomedicines is publishing high quality papers that address the challenges in bringing biological agents or novel targeted strategies through identification, developmentand ultimately to clinical use. It is published quarterly online by MDPI with rapid publication. Biomedicines is covered by ESCI (Web of Science) and PubMed.
Bioscience Reports (www.bioscirep.org; ISSN 1573-4935) provides a home for sound scientific research in all areas of cell biology and molecular life sciences. This fully Open Access journal publishes all papers under the liberal CC BY licence, giving the life science community quality research to share and discuss. Articles are assessed on soundness, providing a home for valid findings and data. Submission to the journal is easy (bioscirep.msubmit.net), and we aim to get a decision to you within 4 weeks of submission. Bioscience Reports is indexed on PubMed, PubMed Central and Web of Science.
The Canceropôle Provence Alpes-Côte d’Azur (PACA) is a public consortium created in 2013 gathering about 850 cognitive and clinical researchers and physicians in 1 region (Mainly Marseille and Nice). The main goal of the Canceropôle PACA is to accelerate translational cancer research, into benefits and improved outcomes for patients. To reach this ambitious objective, the Canceropôle PACA is providing a financial support to research teams by funding their research projects selected via annual calls for projects. It also provides the research teams with an access to technological platforms and biological resources as well as highly qualified staff; and finally supports communication and dissemination activities through different actions as the organization of meetings.
Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Since 1989, we have developed innovative and reliable technologies for scientists and clinicians around the world. Our integrated portfolio of tools covers techniques of sample preparation, cell separation, flow cytometry, cell culture, molecular analysis, and preclinical imaging. The MACS® brand has set standards worldwide and is trusted across basic, translational, and clinical research settings. Our expertise covers research areas like immunology, stem cell biology, neuroscience, and cancer, and clinical research areas that include hematology, graft engineering, as well as apheresis. We are committed to supporting scientists and the scientific community – from comprehensive technical support to training at our MACS Academy. Today, we are more than 2,000 employees in 22 countries – all dedicated to providing solutions that empower scientific discovery and advance cellular therapy.
ARC Foundation for Cancer Research
The Fondation ARC, recognized as an organization of public utility, is 100% dedicated to cancer research. Each year, more than 25 million euros are allocated to research projects that bring hope to patients.
The Fondation ARC identifies, selects, funds and implements promising research programs in all fields of oncology (genetics, immunology, cell biology and metabolism, pharmacology, etc.), promoting multidisciplinary approaches, basic, translational and clinical research, epidemiology, human and social sciences.
These research programs aim to generate new knowledge, develop new concepts and propose new therapeutic solutions for adult and children patients. The Fondation ARC also acts to structure and foster the cancer research ecosystem.
The fight against cancer also requires high-quality information. The Fondation ARC provides the general public and healthcare professionals with tools to improve prevention, medical care and the understanding of the disease.
Guided by public interest and scientific excellence, entirely funded by its donors and testators generosity, the Fondation ARC is a catalyst for research; gathering stakeholders in the fight against cancer and directing research to speed up the development of effective applications for patients.
The Fondation ARC has been accredited by the “Don en confiance” control agency since 1999.
For more information, visit www.fondation-arc.org
SBCF - French Society for Cell Biology
BBA Molecular Cell Research
BBA Molecular Cell Research focuses on understanding the mechanisms of cellular processes at the molecular level. These include aspects of cellular signaling, signal transduction, cell cycle, apoptosis, intracellular trafficking, secretory and endocytic pathways, biogenesis of cell organelles, cytoskeletal structures, cellular interactions, cell/tissue differentiation and cellular enzymology. Also included are studies at the interface between Cell Biology and Biophysics which apply for example novel imaging methods for characterizing cellular processes.